Bellevue Asset Management, LLC Biogen Inc. Transaction History

Bellevue Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$259.0 - $414.71 $16,835 - $26,956	-65 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $5,824 - $6,725	22 Added 51.16%	65 $18,000
Q1 2020 May 13, 2020	BUY	$268.85 - $341.04 $1,344 - $1,705	5 Added 13.16%	43 $13,000
Q4 2019 Feb 13, 2020	BUY	$220.06 - $304.07 $8,362 - $11,554	38 New	38 $11,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Bellevue Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bellevue Asset Management, LLC with notifications on news.